Edition:
United States

People: AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

8.56USD
17 Aug 2018
Change (% chg)

$-0.20 (-2.28%)
Prev Close
$8.76
Open
$8.80
Day's High
$8.95
Day's Low
$8.50
Volume
16,135
Avg. Vol
48,435
52-wk High
$17.39
52-wk Low
$6.95

Bohlen und Halbach, Friedrich von 

Mr. Friedrich von Bohlen und Halbach is Member of Board of Director at AC Immune Ltd October 2015. He is co-founder and managing director of dievini Hopp BioTech holding GmbH & Co. KG. He brings extensive industry experience from Fresenius AG, FAG Kugelfischer, and WASAG-Chemie AG, founded LION bioscience AG in 1997 (now SYGNIS Pharma AG) and served as the companys CEO. Dr. von Bohlen is a board member of various companies of the dievini portfolio and Chairman of Apogenix AG, CureVac AG and Novaliq GmbH. He holds a PhD in Neurobiology from the Swiss Federal Institute of Technology in Zurich, Switzerland.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --